Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-03-01
1999-01-05
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544370, 544360, 544357, 544364, 544231, 544384, 544391, 540492, 540575, 514218, 514255, A61K 31495, C07D40306, C07D40106, C07D24104
Patent
active
058563261
ABSTRACT:
The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.
REFERENCES:
patent: 3491098 (1970-01-01), Archer
patent: 4940793 (1990-07-01), Botre' et al.
patent: 5043268 (1991-08-01), Stock
patent: 5141851 (1992-08-01), Brown et al.
patent: 5238922 (1993-08-01), Graham et al.
patent: 5326773 (1994-07-01), De Solms et al.
patent: 5340828 (1994-08-01), Graham et al.
patent: 5352705 (1994-10-01), Deana et al.
patent: 5428164 (1995-06-01), Thurkauf et al.
patent: 5439918 (1995-08-01), Desolms et al.
patent: 5478934 (1995-12-01), Yuan et al.
patent: 5480893 (1996-01-01), Graham et al.
patent: 5491164 (1996-02-01), De Solms et al.
patent: 5504212 (1996-04-01), De Solms et al.
patent: 5646281 (1997-07-01), Thurkauf et al.
Nagasu et al, Cancer Research 55, pp. 5310-5314, (1995).
Kmonicek et al, Collect. Czech. Commun. 55, pp. 1817-1827, (1990).
J. of Med. Chem., vol. 35, No. 22, pp. 4118-4134 (1992), by E. Carceller, et al.
J. of Med. Chem., vol. 7, No. 2, pp. 154-158 (1964), by O. E. Fancher, et al.
J. of Med. Chem., vol. 38, No. 12, pp. 2251-2255 (1995), by A. Thurkauf, et al.
Gibbs, J.B. et al., "Selective Inhibition of Farnesyl-Protein Transferase Blocks Ras Processing in Vivo," The Journal of Biological Chemistry, vol. 268, No. 11, pp. 7617-7620 (1993).
Goldstein, J.L. et al., "Nonfarnesylated Tetrapeptide Inhibitors of Protein Farnesyltransferase," The Journal of Biological Chemistry, vol. 266, No. 24, pp. 15575-15578 (1991).
James, G.L. et al., Benzodiazepine Peptidomimetic BZ-5B Interrupts the MAP Kinase Activation Pathway in H-Ras-transformed Rat-1 Cells, but Not in Untransformed Cells, The Journal of Biological Chemistry, vol. 369, No. 44, pp. 27705-27714 (1994).
James, G.L. et al., "Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation in Animal Cells", Science, vol. 260, pp. 1937-1942 (1993).
James, G. et al., "Polylysine and CVIM Sequences of K-RasB Dictate Specificity of Prenylation and Confer Resistance to Benzodiazepine Peptidomimetic in Vitro," The Jour. of Biol. Chem., vol. 270, No. 11, pp. 6221-6226 (1995).
Kohl, N.E., et al., "Selective Inhibition of ras-Dependent Transformation by a Farnesyltransferase Inhibitor," Science, vol. 260, pp. 1934-1937 (1993).
Kohl, N.E. et al., "Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice", Proc. Natl. Acad. Sci. USA, Med. Sciences, vol. 91, pp. 9141-9145 (1994).
Kohl, N.E., et al., "Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice," Nature Medicine, vol. 1, No. 8 (1995), pp. 792-797.
Pompliano, D.L., "Steady-State Kinetic Mechanism of Ras Farnesyl:Protein Transferase," Biochemistry, vol. 31, pp. 3800-3807 (1992).
Sepp-Lorenzino, L. et al., "A Peptidomimetic Inhibitor of Farnesyl:Protein Transferase Blocks the Anchorage-dependent and-independent Growth of Human Tumor Cell Lines," Cancer Research, vol. 55, pp. 5302-5309 (1995).
Graham, S.L., "Inhibitors of protein farnesylation: a new approach to cancer chemotherapy," Exp. Opin. Ther. Patents, 5(12) pp. 1269-1285 (1995).
Komoto et al, Chemical Abstracts, vol. 109, No. 231076 (Abstract for JP 63, 183565, Jul. 28, 1988) (1988).
Khosravi-Far et al, Cell Growth & Differentiation 3, pp. 461-469 (1992).
Anthony Neville J.
Ciccarone Terrence M.
Dinsmore Christopher J.
Gomez Robert P.
Hartman George D.
Bernhardt Emily
Daniel Mark R.
Merck & Co. , Inc.
Muthard David A.
LandOfFree
Inhibitors of farnesyl-protein transferase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of farnesyl-protein transferase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of farnesyl-protein transferase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-862532